Genetic evidence and integration of various data sources for classifying uncertain variants into a single model
Year: 2008
Type: article
Abstract: Genetic testing often results in the finding of a variant whose clinical significance is unknown. A number of different approaches have been employed in the attempt to classify such variants. For some variants, case-control, segregation, family history, or other statistical studies can provide strong evidence of direct association with cancer risk. For most variants, other evidence is available that relates to properties of the protein or gene sequence. In this work we propose a Bayesian method for assessing the likelihood that a variant is pathogenic. We discuss the assessment of prior probability, and how to combine the various sources of data into a statistically valid integrated assessment with a posterior probability of pathogenicity. In particular, we propose the use of a two-component mixture model to integrate these various sources of data and to estimate the parameters related to sensitivity and specificity of specific kinds of evidence. Further, we discuss some of the issues involved in this process and the assumptions that underpin many of the methods used in the evaluation process.
Source: Human Mutation
DOI: 10.1002/humu.20897
Authors: David E. Goldgar, Douglas F. Easton, Graham B. Byrnes, Amanda B. Spurdle, Edwin S. Iversen, Marc S. Greenblatt, for the IARC Unclassified Genetic Variants Working Group
Language: English
Topic: Genomics and Rare Diseases
Subfield: Genetics
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2107918293
